The GOP Congress and President Donald Trump spent very little time discussing the broader implications of the tax cut-Medicaid cut bill. As such, it did a disservice to all taxpayers in this ...

But in the states that have tried them, Medicaid work requirements did little to boost employment. Instead, they created ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

Christina Bohannan, who is challenging Rep. Mariannette Miller-Meeks in Iowa's First District, visited Washington County Hospital to discuss the impact spending cuts will have on rural health care.

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so.

The current state budget requires state officials to identify and enact $100 million in public worker health care savings for ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Trump administration is evaluating a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, ...

Genworth Financial enjoyed fortunate timing with a potential $750 million lawsuit windfall coming just days before it reported Q2 earnings.

More than 60 parents, assemblymembers and youth mental health advocates called upon New York State lawmakers to compensate ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...